Risk of CV Events With EFV vs. EFV-free Regimens

NCT02426866 · clinicaltrials.gov ↗

COMPLETED

Status

29612

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV/AIDS

Interventions

DRUG: Efavirenz

Sponsor

Bristol-Myers Squibb

Collaborators

[object Object]